DanDrit Biotech USA, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 11/16/2017
Contact Info
  • Stumpedyssevej 17
  • Horsholm 2970
  • Denmark

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0001527728
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2011
Employees 3 a/o Dec 23, 2016
Company Officers/Contacts
Eric Leire CEO
Robert E. Wolfe CFO
Company Directors
Henrik Grønfeldt-Sørensen
Eric Leire
Rene Sindlev
Robert E. Wolfe
Service Providers
Accounting/Auditing Firm
Gregory & Associates, LLC
19 120th Street
Ocean City, MD, 21842
United States
Securities Counsel
K&L Gates LLP OTCQX Sponsor
200 S. Biscayne Blvd
Suite 3900
Miami, FL, 33131
United States
Investor Relations Firm

Not Available
DDRT Security Details
Share Structure
Market Value1 $61,636,646 a/o Jan 18, 2018
Authorized Shares 100,000,000 a/o Sep 28, 2017
Outstanding Shares 13,727,538 a/o Sep 28, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 7,402,528 a/o Sep 28, 2017
Par Value Not Available
Shareholders of Record 89 a/o Sep 28, 2017
Short Selling Data
Short Interest 60 (-88.12%)
Dec 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security